Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose dexamethasone for high pain responders undergoing total hip arthroplasty
2018-002636-25Phase 4Completed
- Sponsor
- Anaesthesia Department, Hvidovre Hospital, Capital Region of Denmark.
- Start
- Aug 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hip osteoarthritis and hip arthroplasty comparing High-dose dexamethasone with Placebo / standard perioperative care (2 arms). Primary endpoint: Primary: Proportion of patients with VAS > 30 during 5-meter walk test at 24 hours postoperative. Started Aug 2018; status: completed.
02
Drugs
dexamethasone
03
Conditions
hip osteoarthritiship arthroplasty
Beyond the preview
Go deeper on 2018-002636-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002636-25.